Andrew Harbottle
Directeur Technique/Scientifique/R&D chez MDNA Life Sciences, Inc.
Postes actifs de Andrew Harbottle
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MDNA Life Sciences, Inc.
 MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Directeur Technique/Scientifique/R&D | 01/11/2014 | - |
Historique de carrière de Andrew Harbottle
Formation de Andrew Harbottle
| Newcastle University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
MDNA Life Sciences, Inc.
MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Health Services |
- Bourse
- Insiders
- Andrew Harbottle
- Expérience
